dr. patel on the clinical implications of luspatercept approval in mds
Published 4 years ago • 134 plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
1:27
dr. patel on data from the medalist trial in low-risk mds
-
4:20
treating anemia with luspatercept in mds
-
1:19
dr. gerds on luspatercept to treat anemia in myelofibrosis
-
7:32
does luspatercept reduce blood transfusions in mds patients?
-
4:48
alan list: is luspatercept a new option for patients with mds?
-
4:21
evaluating luspatercept in combination with esas for the treatment of anemia in lr-mds
-
2:26
ace-536-mf-001 update: luspatercept for the treatment of anemia in myelofibrosis
-
4:36
commands: luspatercept versus epoetin alfa in lr-mds-associated anemia - results & caveats
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
1:54
what is the future role of luspatercept in patients with low-risk md
-
5:30
commands: luspatercept vs epoetin alfa for anemia in esa-naive lr-mds
-
3:01
long-term results of believe: luspatercept in adults with transfusion-dependent beta-thalassemia
-
0:56
luspatercept for mds-associated anemia
-
1:06
commands trial: luspatercept vs epoetin alfa in lower-risk mds
-
1:40
long-term follow-up of luspatercept: response duration and progression to aml
-
1:38
phase ii trial of luspatercept in myelofibrosis-associated anemia
-
1:39
luspatercept - clinical trial update
-
5:26
nct03194542 trial: luspatercept for the treatment of patients with anemic myelofibrosis
-
2:02
beyond trial update: luspatercept in non-transfusion-dependent β-thalassemia